AJMC® in the Press, December 17, 2021
What We're Reading: J&J Blood Clot Concerns; Abortion Pill Access; Pandemic Health Spending
Contributor: Should Insurance Regulation Be Used to Promote Nontraditional Goals?
Coping Strategies Can Improve Quality of Life, Physical Disability in People With MS
Study on Niemann-Pick Disease Yields New Insights, Novel Variants
Case Report Shows Positive Outcome With Belimumab for CTD-Associated Interstitial Lung Disease
Tubeless, On-Body Automated Insulin Delivery System Shows Benefits for Glucose Control
Disproportionate HIV Risk Among Transgender People Continues
Data Show Erenumab’s Efficacy, Safety in Episodic Migraine After 2 Years
What We’re Reading: Moderna Vaccine Efficacy Reduced; Vaccine Mandate Revived; New Combo Against Breast Cancer
Review Provides Overview of Pulmonary Arterial Hypertension
Sub-Q Isatuximab Combo Offers Safety, Efficacy Profile Comparable With Phase 3 Results in IV Formulation
Findings Are Reported From De-escalation Therapy in Early Breast Cancer
Comparing QOL Among Women With Infertility, PCOS, Obesity
Report Documents Steep Increase of Once-Rare Ocular Fungal Infection in Those With COVID-19
Comorbid Psoriasis, NAFLD Linked With Significantly Impaired Kidney Function
What We’re Reading: Omicron Wave Expected in January; Pfizer COVID-19 Pill Effective vs Variant; JP Morgan Conference Moves Virtual
Comparable, Sustained Efficacy Observed With HNS vs PAP Therapy in OSA
Study: Racial-Ethnic Disparities in T1D Technology Use Worsened From 2017 to 2019
Contributor: New Jersey Has Highest Average In-Network Costs for COVID-19 Complex Hospitalizations
Review Explains Value of Secukinumab for Children, Adolescents With Moderate to Severe Plaque Psoriasis
Avalere Analyst on How Payers Make Cell, Gene Therapy Decisions With Limited Data
Study: 3 Types of COVID-19 Vaccines Deemed Safe for Use in Patients With MS
From Challenges Spring Opportunities for Progress in Daratumumab-Based Clinical Pathways
Study Identifies Risk Factors for Carotid Intima Media Thickness Progression in SLE
Mara McDermott on What's Next for the Value Based Care Coalition
Many Questions Remain in Deciphering, Preventing Atopic March
Dr John Burke: POLARIX Shows Marked Improvement in Patient Outcomes With Pola-R-CHP as First-line Treatment for DLBCL
What We’re Reading: Skipping Medical Care Over Cost; 1-Year Vaccine Anniversary; Overwhelmed MN Hospitals
POLARIX: Upgrading R-CHOP With Polatuzumab Vedotin for Vincristine Improves Progression-Free Survival